IBDEI0QF ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,11882,0)
;;=J1885^^48^580^62^^^^1
;;^UTILITY(U,$J,358.3,11882,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11882,1,2,0)
;;=2^J1885
;;^UTILITY(U,$J,358.3,11882,1,3,0)
;;=3^KETOROLAC TROMETHAMINE 15MG
;;^UTILITY(U,$J,358.3,11883,0)
;;=J1750^^48^580^57^^^^1
;;^UTILITY(U,$J,358.3,11883,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11883,1,2,0)
;;=2^J1750
;;^UTILITY(U,$J,358.3,11883,1,3,0)
;;=3^IRON DEXTRAN 50MG
;;^UTILITY(U,$J,358.3,11884,0)
;;=J1200^^48^580^20^^^^1
;;^UTILITY(U,$J,358.3,11884,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11884,1,2,0)
;;=2^J1200
;;^UTILITY(U,$J,358.3,11884,1,3,0)
;;=3^BENADRYL UP TO 50MG
;;^UTILITY(U,$J,358.3,11885,0)
;;=90283^^48^580^50^^^^1
;;^UTILITY(U,$J,358.3,11885,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11885,1,2,0)
;;=2^90283
;;^UTILITY(U,$J,358.3,11885,1,3,0)
;;=3^HUMAN IG IV
;;^UTILITY(U,$J,358.3,11886,0)
;;=J2430^^48^580^85^^^^1
;;^UTILITY(U,$J,358.3,11886,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11886,1,2,0)
;;=2^J2430
;;^UTILITY(U,$J,358.3,11886,1,3,0)
;;=3^PAMIDRONATE DISODIUM 30MG
;;^UTILITY(U,$J,358.3,11887,0)
;;=J1071^^48^580^103^^^^1
;;^UTILITY(U,$J,358.3,11887,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11887,1,2,0)
;;=2^J1071
;;^UTILITY(U,$J,358.3,11887,1,3,0)
;;=3^TESTOSTERONE CYPIONATE 1MG
;;^UTILITY(U,$J,358.3,11888,0)
;;=J3121^^48^580^104^^^^1
;;^UTILITY(U,$J,358.3,11888,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11888,1,2,0)
;;=2^J3121
;;^UTILITY(U,$J,358.3,11888,1,3,0)
;;=3^TESTOSTERONE ENANTHATE 1MG
;;^UTILITY(U,$J,358.3,11889,0)
;;=J2357^^48^580^110^^^^1
;;^UTILITY(U,$J,358.3,11889,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11889,1,2,0)
;;=2^J2357
;;^UTILITY(U,$J,358.3,11889,1,3,0)
;;=3^XOLAIR 5MG
;;^UTILITY(U,$J,358.3,11890,0)
;;=J0202^^48^580^8^^^^1
;;^UTILITY(U,$J,358.3,11890,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11890,1,2,0)
;;=2^J0202
;;^UTILITY(U,$J,358.3,11890,1,3,0)
;;=3^ALEMTUZUMAB 1MG
;;^UTILITY(U,$J,358.3,11891,0)
;;=J0596^^48^580^22^^^^1
;;^UTILITY(U,$J,358.3,11891,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11891,1,2,0)
;;=2^J0596
;;^UTILITY(U,$J,358.3,11891,1,3,0)
;;=3^C1 ESTERASE INHIBITOR 10U
;;^UTILITY(U,$J,358.3,11892,0)
;;=J0695^^48^580^25^^^^1
;;^UTILITY(U,$J,358.3,11892,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11892,1,2,0)
;;=2^J0695
;;^UTILITY(U,$J,358.3,11892,1,3,0)
;;=3^CEFTOLOZANE 50MG AND TAZOBACTAM 25MG
;;^UTILITY(U,$J,358.3,11893,0)
;;=J0714^^48^580^24^^^^1
;;^UTILITY(U,$J,358.3,11893,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11893,1,2,0)
;;=2^J0714
;;^UTILITY(U,$J,358.3,11893,1,3,0)
;;=3^CEFTAZIDIME AND AVIBACTAM 0.5G/0.125G
;;^UTILITY(U,$J,358.3,11894,0)
;;=J0875^^48^580^29^^^^1
;;^UTILITY(U,$J,358.3,11894,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11894,1,2,0)
;;=2^J0875
;;^UTILITY(U,$J,358.3,11894,1,3,0)
;;=3^DALBAVANCIN 5MG
;;^UTILITY(U,$J,358.3,11895,0)
;;=J1443^^48^580^39^^^^1
;;^UTILITY(U,$J,358.3,11895,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11895,1,2,0)
;;=2^J1443
;;^UTILITY(U,$J,358.3,11895,1,3,0)
;;=3^FERRIC PYROPHOSPHATE CITRIC SOL .01MG
;;^UTILITY(U,$J,358.3,11896,0)
;;=J1447^^48^580^101^^^^1
;;^UTILITY(U,$J,358.3,11896,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,11896,1,2,0)
;;=2^J1447
;;^UTILITY(U,$J,358.3,11896,1,3,0)
;;=3^TBO-FILGRASTIM 1MCG
;;^UTILITY(U,$J,358.3,11897,0)
;;=J1575^^48^580^52^^^^1
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0QF 3799 printed Apr 09, 2024@21:04:54 Page 2
IBDEI0QF ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,11882,0)
+2 ;;=J1885^^48^580^62^^^^1
+3 ;;^UTILITY(U,$J,358.3,11882,1,0)
+4 ;;=^358.31IA^3^2
+5 ;;^UTILITY(U,$J,358.3,11882,1,2,0)
+6 ;;=2^J1885
+7 ;;^UTILITY(U,$J,358.3,11882,1,3,0)
+8 ;;=3^KETOROLAC TROMETHAMINE 15MG
+9 ;;^UTILITY(U,$J,358.3,11883,0)
+10 ;;=J1750^^48^580^57^^^^1
+11 ;;^UTILITY(U,$J,358.3,11883,1,0)
+12 ;;=^358.31IA^3^2
+13 ;;^UTILITY(U,$J,358.3,11883,1,2,0)
+14 ;;=2^J1750
+15 ;;^UTILITY(U,$J,358.3,11883,1,3,0)
+16 ;;=3^IRON DEXTRAN 50MG
+17 ;;^UTILITY(U,$J,358.3,11884,0)
+18 ;;=J1200^^48^580^20^^^^1
+19 ;;^UTILITY(U,$J,358.3,11884,1,0)
+20 ;;=^358.31IA^3^2
+21 ;;^UTILITY(U,$J,358.3,11884,1,2,0)
+22 ;;=2^J1200
+23 ;;^UTILITY(U,$J,358.3,11884,1,3,0)
+24 ;;=3^BENADRYL UP TO 50MG
+25 ;;^UTILITY(U,$J,358.3,11885,0)
+26 ;;=90283^^48^580^50^^^^1
+27 ;;^UTILITY(U,$J,358.3,11885,1,0)
+28 ;;=^358.31IA^3^2
+29 ;;^UTILITY(U,$J,358.3,11885,1,2,0)
+30 ;;=2^90283
+31 ;;^UTILITY(U,$J,358.3,11885,1,3,0)
+32 ;;=3^HUMAN IG IV
+33 ;;^UTILITY(U,$J,358.3,11886,0)
+34 ;;=J2430^^48^580^85^^^^1
+35 ;;^UTILITY(U,$J,358.3,11886,1,0)
+36 ;;=^358.31IA^3^2
+37 ;;^UTILITY(U,$J,358.3,11886,1,2,0)
+38 ;;=2^J2430
+39 ;;^UTILITY(U,$J,358.3,11886,1,3,0)
+40 ;;=3^PAMIDRONATE DISODIUM 30MG
+41 ;;^UTILITY(U,$J,358.3,11887,0)
+42 ;;=J1071^^48^580^103^^^^1
+43 ;;^UTILITY(U,$J,358.3,11887,1,0)
+44 ;;=^358.31IA^3^2
+45 ;;^UTILITY(U,$J,358.3,11887,1,2,0)
+46 ;;=2^J1071
+47 ;;^UTILITY(U,$J,358.3,11887,1,3,0)
+48 ;;=3^TESTOSTERONE CYPIONATE 1MG
+49 ;;^UTILITY(U,$J,358.3,11888,0)
+50 ;;=J3121^^48^580^104^^^^1
+51 ;;^UTILITY(U,$J,358.3,11888,1,0)
+52 ;;=^358.31IA^3^2
+53 ;;^UTILITY(U,$J,358.3,11888,1,2,0)
+54 ;;=2^J3121
+55 ;;^UTILITY(U,$J,358.3,11888,1,3,0)
+56 ;;=3^TESTOSTERONE ENANTHATE 1MG
+57 ;;^UTILITY(U,$J,358.3,11889,0)
+58 ;;=J2357^^48^580^110^^^^1
+59 ;;^UTILITY(U,$J,358.3,11889,1,0)
+60 ;;=^358.31IA^3^2
+61 ;;^UTILITY(U,$J,358.3,11889,1,2,0)
+62 ;;=2^J2357
+63 ;;^UTILITY(U,$J,358.3,11889,1,3,0)
+64 ;;=3^XOLAIR 5MG
+65 ;;^UTILITY(U,$J,358.3,11890,0)
+66 ;;=J0202^^48^580^8^^^^1
+67 ;;^UTILITY(U,$J,358.3,11890,1,0)
+68 ;;=^358.31IA^3^2
+69 ;;^UTILITY(U,$J,358.3,11890,1,2,0)
+70 ;;=2^J0202
+71 ;;^UTILITY(U,$J,358.3,11890,1,3,0)
+72 ;;=3^ALEMTUZUMAB 1MG
+73 ;;^UTILITY(U,$J,358.3,11891,0)
+74 ;;=J0596^^48^580^22^^^^1
+75 ;;^UTILITY(U,$J,358.3,11891,1,0)
+76 ;;=^358.31IA^3^2
+77 ;;^UTILITY(U,$J,358.3,11891,1,2,0)
+78 ;;=2^J0596
+79 ;;^UTILITY(U,$J,358.3,11891,1,3,0)
+80 ;;=3^C1 ESTERASE INHIBITOR 10U
+81 ;;^UTILITY(U,$J,358.3,11892,0)
+82 ;;=J0695^^48^580^25^^^^1
+83 ;;^UTILITY(U,$J,358.3,11892,1,0)
+84 ;;=^358.31IA^3^2
+85 ;;^UTILITY(U,$J,358.3,11892,1,2,0)
+86 ;;=2^J0695
+87 ;;^UTILITY(U,$J,358.3,11892,1,3,0)
+88 ;;=3^CEFTOLOZANE 50MG AND TAZOBACTAM 25MG
+89 ;;^UTILITY(U,$J,358.3,11893,0)
+90 ;;=J0714^^48^580^24^^^^1
+91 ;;^UTILITY(U,$J,358.3,11893,1,0)
+92 ;;=^358.31IA^3^2
+93 ;;^UTILITY(U,$J,358.3,11893,1,2,0)
+94 ;;=2^J0714
+95 ;;^UTILITY(U,$J,358.3,11893,1,3,0)
+96 ;;=3^CEFTAZIDIME AND AVIBACTAM 0.5G/0.125G
+97 ;;^UTILITY(U,$J,358.3,11894,0)
+98 ;;=J0875^^48^580^29^^^^1
+99 ;;^UTILITY(U,$J,358.3,11894,1,0)
+100 ;;=^358.31IA^3^2
+101 ;;^UTILITY(U,$J,358.3,11894,1,2,0)
+102 ;;=2^J0875
+103 ;;^UTILITY(U,$J,358.3,11894,1,3,0)
+104 ;;=3^DALBAVANCIN 5MG
+105 ;;^UTILITY(U,$J,358.3,11895,0)
+106 ;;=J1443^^48^580^39^^^^1
+107 ;;^UTILITY(U,$J,358.3,11895,1,0)
+108 ;;=^358.31IA^3^2
+109 ;;^UTILITY(U,$J,358.3,11895,1,2,0)
+110 ;;=2^J1443
+111 ;;^UTILITY(U,$J,358.3,11895,1,3,0)
+112 ;;=3^FERRIC PYROPHOSPHATE CITRIC SOL .01MG
+113 ;;^UTILITY(U,$J,358.3,11896,0)
+114 ;;=J1447^^48^580^101^^^^1
+115 ;;^UTILITY(U,$J,358.3,11896,1,0)
+116 ;;=^358.31IA^3^2
+117 ;;^UTILITY(U,$J,358.3,11896,1,2,0)
+118 ;;=2^J1447
+119 ;;^UTILITY(U,$J,358.3,11896,1,3,0)
+120 ;;=3^TBO-FILGRASTIM 1MCG
+121 ;;^UTILITY(U,$J,358.3,11897,0)
+122 ;;=J1575^^48^580^52^^^^1
